International Consortium For Health Outcomes Measurement Inc is located in Boston, MA. The organization was established in 2013. According to its NTEE Classification (E70) the organization is classified as: Public Health, under the broad grouping of Health Care and related organizations. As of 12/2022, International Consortium For Health Outcomes Measurement Inc employed 11 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. International Consortium For Health Outcomes Measurement Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, International Consortium For Health Outcomes Measurement Inc generated $2.8m in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 5.7% each year. All expenses for the organization totaled $1.5m during the year ending 12/2022. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
TO DEFINE A GLOBAL STANDARD SET OF OUTCOME MEASURES THAT REALLY MATTER TO PATIENTS FOR THE MOST RELEVANT MEDICAL CONDITIONS AND DRIVE ADOPTION OF THESE MEASURES SEE SCH O.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE CORE OF ICHOM'S WORK IS THE DEVELOPMENT OF ICHOM SETS OF PATIENT-CENTERED OUTCOME MEASURES. ICHOM CONVENES GLOBAL PATIENT, CLINICAL, MEASUREMENT, AND RESEARCH LEADERS TO DEFINE OUTCOMES IMPORTANT TO PATIENTS AND DEVELOP CONSENSUS-BASED MEASURE SETS. ICHOM FACILITATES AN EIGHT TO TWELVE-MONTH LONG PROCESS TO DEFINE EACH SET OF OUTCOMES. IN 2023 ICHOM LAUNCHED THE ICHOM PEDIATRIC AND ADULT EPILEPSY SET OF PATIENT-CENTERED OUTCOME MEASURES WHICH ALLOWS FOR TRACKING PATIENT-CENTERED OUTCOMES IN PEOPLE LIVING WITH EPILEPSY FROM THE AGE OF 1 MONTH ONWARDS, AS WELL AS STARTED THE GROUND-BREAKING DEVELOPMENT OF AN OBESITY SET, DUE TO BE COMPLETED IN Q2 NEXT YEAR. ANOTHER CONTINUATION IN ICHOM'S WORK THIS YEAR HAS BEEN UPDATING PREVIOUSLY PUBLISHED SETS, NECESSARY TO KEEP THE SETS RELEVANT AND FUNCTIONAL IN CLINICAL SPACE. IN 2023 STARTED THE REVIEW OF THE ONCOLOGY SETS, DUE TO BE COMPLETED BY 2023.
ICHOM IS COMMITTED TO DRIVING THE USE OF THESE RESOURCES TO SCALE UP PATIENT-CENTERED MEASUREMENT AND CARE TRANSFORMATION. ONCE DEVELOPED, ICHOM AND ITS PARTNERS INVEST IN PRESENTING THESE PUBLIC GOOD RESOURCES AS OPEN-ACCESS TOOLS, IN THE FORM OF PDF IMPLEMENTATION GUIDES AND OPEN-ACCESS SCIENTIFIC PUBLICATIONS. IN ORDER TO DRIVE THE ADOPTION OF THESE MEASURES, ICHOM ALSO OFFERS ENHANCED IMPLEMENTATION SUPPORT, INCLUDING IT-READY MEASURES MAPPED FOR INTEROPERABILITY STANDARDS, COACHING, ACCREDITATION, AND LEARNING MODELS. IN 2023, ICHOM ANNOUNCED THAT THEY NOW SUPPORT INTEROPERABILITY WITH OUR SETS OF PATIENT-CENTERED OUTCOME MEASURES THROUGH FHIR HL7. THIS IS A KEY DEVELOPMENT AS THEY SEEK TO MAKE SETS AS USABLE AS POSSIBLE IN HEALTHCARE SYSTEMS WORLDWIDE. FHIR, (FAST HEALTHCARE INTEROPERABILITY RESOURCES) AND HL7 INTEROPERABILITY STANDARDS ENSURE DATA FROM DISPARATE SOURCES IS COMPATIBLE AND USABLE, AND WILL MAKE THE COLLECTION AND ANALYSIS OF ICHOM SET DATA MUCH EASIER AND FASTER. THIS YEAR ICHOM HAS OFFICIALLY PUBLISHED AN IMPLEMENTATION GUIDE IN THE ONCOLOGY SPACE, BREAST CANCER. ICHOM ALSO CONTINUES TO PROVIDE AVAILING IMPLEMENTATION SUPPORT, TRAINING AND COACHING, AND ACCREDITS ORGANIZATIONS THAT ARE PROVIDING EXEMPLARY CARE.
ICHOM CONTINUES TO BE THE LEADING ORGANIZATION IN TERMS OF CONVENING MULTI-NATIONAL LEARNING COMMUNITIES TO DEMONSTRATE IMPACT OF STANDARDIZED OUTCOME MEASUREMENT, THIS YEAR GROWING THEIR ONLINE NETWORK TO NEARLY 30,000 INDIVIDUALS. IN 2023, ICHOM HELD THEIR SECOND LARGEST IN-PERSON VALUE-BASED HEALTHCARE CONFERENCE CONVENING 600 INDIVIDUALS FROM 46 COUNTRIES, PARTICIPATING IN SEMINARS AND WORKSHOPS ACROSS THREE DAYS. ICHOM HAS ALSO CONTINUED EFFORTS TO DEVELOP AN UPDATED AND EXPANDED LIBRARY OF ICHOM CASE STUDIES, WITH FIVE EITHER COMPLETED OR IN PROGRESS THIS YEAR.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Suzanne Gaunt President/ceo (thru 10/22) | Officer | 40 | $243,849 |
Greg Robinson Chief Technology Officer | 40 | $164,999 | |
Neo Tapela Chief Strategy Officer | 40 | $124,669 | |
Ben Cordle Chief Marketing Officer | 40 | $113,216 | |
Michael E Porter Chair Emeritus | OfficerTrustee | 1 | $0 |
Stefan Larsson Director | Trustee | 1 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Interactive Pharma Solutions Technical Research | 12/30/19 | $125,944 |
Rucci Bardaro & Falzone Outsourced Cfo | 12/30/19 | $136,935 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $2,075,771 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $2,075,771 |
Total Program Service Revenue | $383,760 |
Investment income | $0 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $2,805,340 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $243,849 |
Compensation of current officers, directors, key employees. | $102,417 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $366,336 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $98,329 |
Payroll taxes | $34,251 |
Fees for services: Management | $0 |
Fees for services: Legal | $1,091 |
Fees for services: Accounting | $33,100 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $40,164 |
Advertising and promotion | $433 |
Office expenses | $35,006 |
Information technology | $106,609 |
Royalties | $0 |
Occupancy | $0 |
Travel | $1,454 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $395,118 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $15,393 |
All other expenses | $0 |
Total functional expenses | $1,492,311 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $110,050 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $380,000 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $94,989 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $23,741 |
Total assets | $608,780 |
Accounts payable and accrued expenses | $93,396 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $93,396 |
Net assets without donor restrictions | $515,384 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $608,780 |